Anales de la RANM

14 A N A L E S R A N M R E V I S T A F U N D A D A E N 1 8 7 9 NOSOLOGÍA EN EL SIGLO XXI: DEFINIENDO LA SARCOPENIA Alfonso J. Cruz Jentoft An RANM. 2021;138(01): 10 - 15 1. Sanchez-Rodriguez D, Marco E, Cruz-Jentoft AJ. Defining sarcopenia: some caveats and challenges. Curr Opin Clin Nutr Metab Care. 2020;23(2):127-132. 2. Rosenberg IH. Sarcopenia: origins and clinical relevance. Clin Geriatr Med. 2011;27(3):337- 339. 3. Workshop on sarcopenia: muscle atrophy in old age. Airlie, Virginia, September 19-21, 1994. Proceedings. J Gerontol A Biol Sci Med Sci. 1995;50 Spec No:1-161. 4. Clark BC, Manini TM. Functional consequences of sarcopenia and dynapenia in the elderly. Curr Opin Clin Nutr Metab Care. 2010;13(3):271-276. 5. Delmonico MJ, Harris TB, Lee J-S, et al. Alter- native definitions of sarcopenia, lower extrem- ity performance, and functional impairment with aging in older men and women. J Am Geri- atr Soc. 2007;55(5):769-774. 6. Studenski S, Perera S, Patel K, et al. Gait speed and survival in older adults. JAMA. 2011;305(1):50-58. 7. Clark BC, Manini TM. Sarcopenia =/= dy- napenia. J Gerontol A Biol Sci Med Sci. 2008;63(8):829-834. 8. Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et al. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Age- ing. 2010;39(4):412-423. 9. Cruz-Jentoft AJ, Landi F, Topinková E, Michel J-P. Understanding sarcopenia as a geriatric syndrome. Curr Opin Clin Nutr Metab Care. 2010;13(1):1-7. 10. Cruz-Jentoft AJ. Sarcopenia, the last organ in- sufficiency. Eur Geriatr Med. 2016;7-8. 11. Sayer AA, Syddall H, Martin H, Patel H, Baylis D, Cooper C. The developmental origins of sar- copenia. J Nutr Health Aging. 2008;12(7):427- 432. 12. Muscaritoli M, Anker SD, Argilés J, et al. Con- sensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by Special Interest Groups (SIG) «cachexia-an- orexia in chronic wasting diseases» and «nu- trition in geriatrics». Clin Nutr Edinb Scotl. 2010;29(2):154-159. 13. Suzan V, Suzan AA. A bibliometric analysis of sarcopenia: top 100 articles. Eur Geriatr Med. 2021;12(1):185-191. 14. Fielding RA, Vellas B, Evans WJ, et al. Sarcope- nia: an undiagnosed condition in older adults. Current consensus definition: prevalence, eti- ology, and consequences. International work- ing group on sarcopenia. J Am Med Dir Assoc. 2011;12(4):249-256. 15. Morley JE, Abbatecola AM, Argiles JM, et al. Sarcopenia with limited mobility: an inter- national consensus. J Am Med Dir Assoc. 2011;12(6):403-409. 16. Chen L-K, Liu L-K, Woo J et al. Sarcopenia in Asia: consensus report of the Asian Working Group for Sarcopenia. J Am Med Dir Assoc. 2014;15(2):95-101. 17. Studenski SA, Peters KW, Alley DE, et al. The FNIH sarcopenia project: rationale, study de- scription, conference recommendations, and final estimates. J Gerontol A Biol Sci Med Sci. 2014;69(5):547-558. 18. Beaudart C, Zaaria M, Pasleau F, Reginster J-Y, Bruyère O. Health Outcomes of Sarcopenia: A Systematic Review and Meta-Analysis. PloS One. 2017;12(1):e0169548. 19. Zhao Y, Zhang Y, Hao Q, Ge M, Dong B. Sarco- penia and hospital-related outcomes in the old people: a systematic review and meta-analysis. Aging Clin Exp Res. 2019;31(1):5-14. 20. Yeung SSY, Reijnierse EM, Pham VK, et al. Sar- copenia and its association with falls and frac- tures in older adults: A systematic review and meta-analysis. J Cachexia Sarcopenia Muscle. 2019;10(3):485-500. 21. Anker SD, Morley JE, von Haehling S. Welcome to the ICD-10 code for sarcopenia. J Cachexia Sarcopenia Muscle. 2016;7(5):512-514. 22. Vellas B, Fielding RA, Bens C, et al. Impli- cations of ICD-10 for Sarcopenia Clinical Practice and Clinical Trials: Report by the International Conference on Frailty and Sar- copenia Research Task Force. J Frailty Aging. 2018;7(1):2-9. 23. .Sayer AA, Syddall HE, Gilbody HJ, Denni- son EM, Cooper C. Does sarcopenia originate in early life? Findings from the Hertfordshire cohort study. J Gerontol A Biol Sci Med Sci. 2004;59(9):M930-934. 24. Buckinx F, Landi F, Cesari M, et al. Pitfalls in the measurement of muscle mass: a need for a reference standard. J Cachexia Sarcopenia Mus- cle. 2018;9(2):269-278. 25. Cruz-Jentoft AJ, Bahat G, Bauer J, et al. Sar- copenia: revised European consensus on defini- tion and diagnosis. Age Ageing. 2019;48(1):16- 31. 26. Zanker J, Scott D, Reijnierse EM, et al. Estab- lishing an Operational Definition of Sarcopenia in Australia and New Zealand: Delphi Method Based Consensus Statement. J Nutr Health Ag- ing. 2019;23(1):105-110. 27. Chen L-K, Woo J, Assantachai P, et al. Asian Working Group for Sarcopenia: 2019 Consen- sus Update on Sarcopenia Diagnosis and Treat- ment. J Am Med Dir Assoc. 2020;21(3):300-307. e2. 28. Bhasin S, Travison TG, Manini TM, et al. Sar- copenia Definition: The Position Statements of the Sarcopenia Definition and Outcomes Con- sortium. J Am Geriatr Soc. 2020;68(7):1410- 1418. 29. Cawthon PM, Manini T, Patel SM, et al. Puta- tive Cut-Points in Sarcopenia Components and Incident Adverse Health Outcomes: An SDOC Analysis. J Am Geriatr Soc. 2020;68(7):1429- 1437. 30. Evans WJ, Hellerstein M, Orwoll E, Cummings S, Cawthon PM. D3 -Creatine dilution and the importance of accuracy in the assessment of skeletal muscle mass. J Cachexia Sarcopenia Muscle. 2019;10(1):14-21. 31. Cruz-Jentoft AJ, Sayer AA. Sarcopenia. Lancet Lond Engl. 2019;393(10191):2636-2646. BIBLIOGRAFÍA

RkJQdWJsaXNoZXIy ODI4MTE=